跨诊断症状聚类及其与脑、行为、日常功能的关联
该横断面研究分析420名重性抑郁障碍、惊恐障碍、创伤后应激障碍及健康对照者,采用层次聚类机器学习方法识别跨诊断症状亚型,并在独立样本中验证。研究识别出6个症状亚型,这些亚型在认知控制、工作记忆、脑电β功率、社会功能能力和情绪韧性上存在差异。
要点
- 跨诊断样本中识别出6个症状亚型,并在独立样本中重复验证。
- 亚型在认知控制、工作记忆、脑电β功率及社会功能上表现不同。
- 亚型划分跨越DSM-IV诊断边界,可能有助于匹配治疗选择。
核心结论
- 研究提出并验证了一种在跨诊断样本中识别症状亚型的数据驱动方法,所识别的6个亚型在行为、脑功能和日常功能层面具有连贯差异。
研究设计与样本
- 横断面研究,分析脑研究与整合神经科学网络基金会数据库数据,2006-2010年在悉尼大学和阿德莱德大学采集,2013-2017年在斯坦福大学重复验证。
- 纳入420名参与者:重性抑郁障碍100例、惊恐障碍53例、创伤后应激障碍47例、健康对照220例。
- 采用层次聚类机器学习算法基于自我报告的负性心境、焦虑和应激症状分类,并在独立样本中检验稳健性和可推广性。
主要发现
- 识别出6个亚型:紧张型81例(19%)、焦虑唤醒型55例(13%)、广泛焦虑型38例(9%)、快感缺失型29例(7%)、忧郁型37例(9%)、常模心境型180例(43%),并在独立样本中重复验证。
- 亚型在认知控制(F5,383=5.13,P<.001,ηp2=0.063)、工作记忆(F5,401=3.29,P=.006,ηp2=0.039)上存在差异。
- 亚型在静息范式脑电β功率(F5,357=3.84,P=.002,ηp2=0.051)和情绪范式脑电β功率(F5,365=3.56,P=.004,ηp2=0.047)上存在差异。
- 亚型在社会功能能力(F5,414=21.33,P<.001,ηp2=0.205)和情绪韧性(F5,376=15.10,P<.001,ηp2=0.171)上存在差异。
临床怎么用
- 症状亚型可跨越DSM-IV诊断边界,为按症状-行为-脑功能-日常功能匹配治疗提供数据驱动框架。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The symptoms that define mood, anxiety, and trauma disorders are highly overlapping across disorders and heterogeneous within disorders. It is unknown whether coherent subtypes exist that span multiple diagnoses and are expressed functionally (in underlying cognition and brain function) and clinically (in daily function). The identification of cohesive subtypes would help disentangle the symptom overlap in our current diagnoses and serve as a tool for tailoring treatment choices. OBJECTIVE: To propose and demonstrate 1 approach for identifying subtypes within a transdiagnostic sample. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study analyzed data from the Brain Research and Integrative Neuroscience Network Foundation Database that had been collected at the University of Sydney and University of Adelaide between 2006 and 2010 and replicated at Stanford University between 2013 and 2017. The study included 420 individuals with a primary diagnosis of major depressive disorder (n = 100), panic disorder (n = 53), posttraumatic stress disorder (n = 47), or no disorder (healthy control participants) (n = 220). Data were analyzed between October 2016 and October 2017. MAIN OUTCOMES AND MEASURES: We followed a data-driven approach to achieve the primary study outcome of identifying transdiagnostic subtypes. First, machine learning with a hierarchical clustering algorithm was implemented to classify participants based on self-reported negative mood, anxiety, and stress symptoms. Second, the robustness and generalizability of the subtypes were tested in an independent sample. Third, we assessed whether symptom subtypes were expressed at behavioral and physiological levels of functioning. Fourth, we evaluated the clinically meaningful differences in functional capacity of the subtypes. Findings were interpreted relative to a complementary diagnostic frame of reference. RESULTS: Four hundred twenty participants with a mean (SD) age of 39.8 (14.1) years were included in the final analysis; 256 (61.0%) were female. We identified 6 distinct subtypes characterized by tension (n=81; 19%), anxious arousal (n=55; 13%), general anxiety (n=38; 9%), anhedonia (n=29; 7%), melancholia (n=37; 9%), and normative mood (n=180; 43%), and these subtypes were replicated in an independent sample. Subtypes were expressed through differences in cognitive control (F5,383 = 5.13, P < .001, ηp2 = 0.063), working memory (F5,401 = 3.29, P = .006, ηp2 = 0.039), electroencephalography-recorded β power in a resting paradigm (F5,357 = 3.84, P = .002, ηp2 = 0.051), electroencephalography-recorded β power in an emotional paradigm (F5,365 = 3.56, P = .004, ηp2 = 0.047), social functional capacity (F5,414 = 21.33, P < .001, ηp2 = 0.205), and emotional resilience (F5,376 = 15.10, P < .001, ηp2 = 0.171). CONCLUSIONS AND RELEVANCE: These findings offer a data-driven framework for identifying robust subtypes that signify specific, coherent, meaningful associations between symptoms, behavior, brain function, and observable real-world function, and that cut across DSM-IV-defined diagnoses of major depressive disorder, panic disorder, and posttraumatic stress disorder.
引用
- Grisanzio KA, Goldstein-Piekarski AN, Wang MY, et al. Transdiagnostic Symptom Clusters and Associations With Brain, Behavior, and Daily Function in Mood, Anxiety, and Trauma Disorders. JAMA Psychiatry. 2018. PMID: 29197929. doi:10.1001/jamapsychiatry.2017.3951
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。